Publications

2011
Other Unpublished Work

From Farms to Fuel Tanks: Collective Actors and New-Venture Innovation in the U.S. Biodiesel Fuel Sector

By: Shon R. Hiatt

Little is known about the influence of collective actors on innovative technological recombinations by new ventures. Using data from U.S. biodiesel producers, I examine how the efforts of multiple collective actors (farm associations) to promote varying types of... View Details

Keywords: Alliances; Agribusiness; Energy Sources; Innovation and Invention; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; United States

01 Nov 2024
In Practice

Layoffs Surging in a Strong Economy? Advice for Navigating Uncertain Times

decision about entrepreneurship Starting your own company after a layoff is a significant decision. While it may seem like an opportune time, research suggests there are some important considerations. “Entrepreneurs coming from high-tech sectors such as View Details

Keywords: by Rachel Layne; Technology; Information Technology

06 Oct 2020
Blog Post

2+2 Where Are They Now Spotlight: Curtis Wu (MBA 2018)

Can you describe your role?I currently work at Amgen Inc at their global HQ in Southern California. Amgen is the largest independent biotechnology company in the world by revenue and our top medicines include autoimmune drug Enbrel, white... View Details

01 Aug 2002
News

For Alumni Only: Breakthrough Insights Program Debuts

case on the biotechnology firm Biogen, where a seemingly innocuous decision to license databases of new proteins discovered through genomic research wound up completely transforming the company's product-development process. As Vietor led... View Details

Keywords: Laura Singleton

17 Mar 2009
First Look

First Look: March 17, 2009

markets for upstream inputs such as scientific knowledge, proximity also may matter for licensing, which they conceptualize as downstream end markets for small biotechnology firms. They examine whether co-location affects the likelihood... View Details

Keywords: Martha Lagace

02 Feb 2021
Blog Post

Finding My Focus in Health care Amidst a Global Pandemic

biotechnology and health-tech companies. After about a year and a half, I went to work at one of JPM’s clients to build their Growth Strategy team. After an interesting first several months, I found myself testifying as a whistleblower to... View Details

26 Jun 2000
Research & Ideas

Presentation Round-Up

recently joined with the private company Celera Genomics to announce the cracking of the human genetic code.) Increasing interest in such research has led to complex legal tangles. Patent attorney Brenda Herschbach Jarrell of Choate, Hall & Stewart, who specializes... View Details

Keywords: by Martha Lagace & Kenneth Liss; Technology; Communications; Telecommunications

01 Dec 2004
News

The Future of Stem Cells

sickle cell anemia.) A board member and former chair of the Massachusetts Biotechnology Council, Fisher says states are stepping up to fund stem-cell work, partly in response to their constituents who want the jobs and businesses — as... View Details

Keywords: Garry Emmons

31 Aug 2010
First Look

First Look: August 31

a national sample of 6,000 life scientists whose careers span more than 20 years. We find sharp gender differences in participation in for-profit ventures, which we measure as the likelihood of joining the scientific advisory board (SAB) of a View Details

Keywords: Sean Silverthorne

May 2015
Case

Transforming Alkermes into a Global Biopharmaceutical Company

By: C. Fritz Foley and Nicholas Haas

In the summer of 2011, Jim Frates, CFO of Alkermes faced choices about how to finance the acquisition of Dublin, Ireland-based Elan Drug Technologies (EDT)—a deal that was expected to close in the fall. The case describes the history of Alkermes, provides information... View Details

Keywords: Financing; Debt; Merger; CFO; Financial Management; Biotechnology Industry; Biotechnology Industry; United States; Europe

April 2011
Teaching Note

Office of Technology Transfer - Shanghai Institutes for Biological Sciences (TN)

By: Willy Shih and Sen Chai

Teaching Note for 611057. View Details

Keywords: Patents; Rights; Infrastructure; Multinational Firms and Management; Research and Development; Complexity; Commercialization; Technology Adoption; Motivation and Incentives; Biotechnology Industry; Biotechnology Industry; Shanghai

March 2011 (Revised February 2012)
Case

Innovation and Growth at Actelion Ltd.

By: Gary P. Pisano, Daniela Beyersdorfer and Ruth Dittrich

In late 2010, Jean-Paul Clozel, CEO of the Swiss biotech pharmaceuticals firm Actelion, looks back on a successful decade. The small venture that he had started with a few of his scientist colleagues in the late 1990s to discover novel medicine in a research-driven... View Details

Keywords: Business Model; Talent and Talent Management; Innovation and Management; Leadership; Growth and Development Strategy; Product Development; Organizational Culture; Research and Development; Biotechnology Industry; Biotechnology Industry; Switzerland

February 2009
Case

Avid Radiopharmaceuticals: The Venture Debt Question

By: Matthew Rhodes-Kropf and Ann Leamon

The CEO of a promising biotech company must decide how to respond to the macro-economic slump of late 2008. He had planned to pursue an aggressive schedule, moving the firm's Alzheimer's and Parkinson's disease imaging compounds through clinical trials and into the... View Details

Keywords: Financial Crisis; Entrepreneurship; Borrowing and Debt; Venture Capital; Financial Management; Investment; Health Testing and Trials; Expansion; Biotechnology Industry; Biotechnology Industry

January 2009 (Revised July 2009)
Case

Targanta Therapeutics: Hitting a Moving Target

By: Arthur A. Daemmrich

This case explores regulatory, product testing, and business strategy at Targanta Therapeutics, a biotech company preparing its first new drug application to the FDA. In October 2007, Mark Leuchtenberger, president and CEO of Targanta—which has just held a successful... View Details

Keywords: Decision Choices and Conditions; Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Development; Business and Government Relations; Business Strategy; Biotechnology Industry; Biotechnology Industry

September 2008
Teaching Note

Chi Mei Optoelectronics (TN)

By: Willy C. Shih

Teaching Note for [608-123]. View Details

Keywords: Diversification; Information Technology; Market Entry and Exit; Standards; Industry Clusters; Supply Chain; Production; Experience and Expertise; Biotechnology Industry; Biotechnology Industry; Taiwan; Asia; Korean Peninsula; China

September 2007 (Revised May 2009)
Case

Syndexa and Technology Transfer at Harvard University

By: Richard G. Hamermesh and David Kiron

Gokhan Hotamisligil is a star researcher at Harvard School of Public Health who has made groundbreaking discoveries linking fat cells, inflammation, and diabetes. He now wants to form a company to commercialize these discoveries. At the same time, Isaac Kohlberg, the... View Details

Keywords: Business Startups; Higher Education; Entrepreneurship; Innovation and Invention; Intellectual Property; Rights; Agreements and Arrangements; Science-Based Business; Commercialization; Biotechnology Industry; Biotechnology Industry